MC1 Diabetes Mellitus: Challenges to Optimal Management

Program: Master Clinician Sessions
Clinical Session
Saturday, April 2, 2016: 4:45 PM-5:45 PM
Hall B2 (BCEC)
Jane E Reusch, MD, Denver Veterans Administration Medical Center, Denver, CO
Jennifer L Larsen, MD, University of Nebraska Medical Center, Omaha, NE and Olufemi Adetola Fasanmade, MBBS FACE, Lagos University Teaching Hospital, Lagos, Nigeria

Nothing to Disclose: JER, BAC, SD Disclosure Not Provided: JLL, OAF, AL, CCL, MTM


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire